Clinical Trial Update: Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donor peripheral stem cell or bone marrow transplant for relapsed or refractory metastatic kidney cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Snippet

Sponsor: University of Rochester | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED